Developer docs
API playgroundTry for free, no card

Search company profiles

GSI Lab

Full company profile

uuid000gmv9

Namestring
GSI Lab
Legal namestring
PT Genomik Solidaritas Indonesia
Websiteurl
gsilab.id
Company typeenum
Private
Founded yearint
2020
Descriptiontext

GSI Lab (legally PT Genomik Solidaritas Indonesia) is a Jakarta-based medical laboratory founded in 2020 as a social entrepreneurship initiative to expand access to COVID-19 testing in Indonesia. The company operates five drive-thru and walk-in testing centers across the Greater Jakarta region (Cilandak, Kuningan, Cengkareng, Bintaro, and Depok) and offers home and on-site corporate testing services. Its core technology stack is RT-PCR plus rapid antigen and antibody testing, with a proprietary sample-collection innovation called PCR Kumur (#AntiColok), a first-in-Indonesia gargle-based RT-PCR method with reported 93-98% sensitivity. The lab also runs a Whole Genome Sequencing (WGS) capability through its #SolidaritySequence program, the only private laboratory supporting the Indonesian government's SARS-CoV-2 variant surveillance, and has contributed 4,600 WGS samples to the GISAID database.

The business operates on a unit-pricing, pay-as-you-go model across five core products (Swab Antigen at Rp95,000; 24-hour PCR at Rp275,000; PCR Kumur at Rp350,000; S-RBD Quantitative Antibody at Rp249,000; and Same-Day PCR at Rp450,000), distributed through direct-to-consumer channels (walk-in, drive-thru, home service) and an enterprise field sales motion targeting corporate clients such as Kredivo, Shopee, Indika Energy, Petrosea, Kideco, and Mobil. Cumulative outcomes include 700,000+ tests conducted and 6,000+ free PCR tests donated to frontliners and under-served communities, supported by Rp4.4 billion+ in cumulative donations from foundations (Temasek, Tanoto) and corporate sponsors. The company is officially registered as a Laboratorium Jejaring Pemeriksa COVID-19 with the Ministry of Health, integrated with the NAR reporting system and PeduliLindungi app.

In 2023 GSI Lab began extending beyond COVID-19 through the Batik Pelangi rare-disease genomic program (May 2023) and joined Filantropi Indonesia (February 2023), signaling a strategic pivot toward broader molecular diagnostics. Leadership is founder-led under CEO dr. Nino Susanto, with a Senior Research Fellow (PhD) and biomedical engineering staff supporting genomic R&D. Revenue has not been publicly disclosed, and the company remains a privately held social enterprise without documented institutional funding rounds beyond a 2022 investment associated with Alpha JWC Ventures / YCAB Ventures.

Short descriptiontext

GSI Lab is a Jakarta-based medical laboratory operating COVID-19 RT-PCR, antigen, and antibody testing across five Greater Jakarta locations, plus corporate on-site services and a government-affiliated whole genome sequencing surveillance program for SARS-CoV-2 variant tracking.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersJakarta, Indonesia
HQ citystring
Jakarta
HQ countrystring
Indonesia
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
COVID-19 PCR testing, medical laboratory services, antigen rapid testing, genomic surveillance services, antibody blood testing
Industry3 codes
PRIMARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAGAEAA
Central Laboratory Services (Core Lab Operations)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAJAIAN
Laboratory Informatics & Reporting (LIMS/ELR) Public Health Networks
Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Laboratories & Reference Testing Networks
NAICS code1 code
  • Medical Laboratories621511
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Medical Laboratory Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1COVID-19 Testing Services
TypeOne Time License
Description

Direct revenue from providing RT-PCR tests, rapid antigen tests, and antibody tests to individual consumers and corporate clients. Services offered at varying turnaround times and price points.

gsilab.id
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Pricing details5 tiers
1Swab Antigen - Rapid Test
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Rp95,000 per test with results in 30 minutes

gsilab.id
2Same Day PCR Swab
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Rp450,000 per test with results by 23:59 on the same day

gsilab.id
324 Hour PCR Swab
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Rp275,000 per test with results within 24 hours

gsilab.id
4S-RBD Quantitative Antibody Test
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Rp249,000 per test for antibody quantification

gsilab.id
5PCR Kumur (Gargle) Test
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Rp350,000 per test using non-invasive gargle sample collection method

gsilab.id
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

GSI Lab operates a private medical laboratory in Greater Jakarta providing COVID-19 testing services — antigen rapid tests, multiple PCR swab turnaround options (same-day and 24-hour), S-RBD quantitative antibody tests, and a proprietary gargle-based PCR (PCR Kumur / #AntiColok). It also runs Whole Genome Sequencing for SARS-CoV-2 variant surveillance and operates donation-funded free testing programs. Services are delivered via drive-thru/walk-in centers, home visits, and corporate on-site testing.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • More than 700,000 tests conducted
+3 more records
Product overview1 text field

GSI Lab (Genomik Solidaritas Indonesia) is a social entrepreneurship initiative providing COVID-19 testing services in Indonesia. The core offering consists of five main testing products: Swab Antigen (rapid test, 30-minute results), PCR Swab Same Day (same-day results), PCR Swab 24-hour (next-day results), S-RBD Quantitative Antibody Test (immunity measurement), and PCR Kumur (gargle-based PCR, #AntiColok innovation). These are delivered through three service channels: Drive/Walk Thru at 5 locations, Home Services for groups, and standard walk-in testing. GSI Lab also operates social programs including free PCR testing for frontliners (#SwabAndSave) and free Whole Genome Sequencing for variant surveillance (#SolidaritySequence). The company is registered as a COVID-19 testing laboratory affiliated with the Indonesian Ministry of Health's NAR system and connects results to the PeduliLindungi government app.

Product and service7 records
1Swab Antigen
CategoryDiagnostic testing service
Description

Rapid COVID-19 antigen test using nasal swab sample collection. Provides results within 30 minutes. Most affordable testing option at Rp95,000 per test. Targeted at individual consumers and corporate clients needing fast, low-cost screening.

2PCR Swab Same Day
CategoryDiagnostic testing service
Description

Same-day PCR test with results delivered by 23:59 on the same working day. Detects SARS-CoV-2 genetic material using nasal and oral swab sample collection, includes CT values. Most accurate detection method. Priced at Rp450,000 per test.

3PCR Swab 24 jam
CategoryDiagnostic testing service
Description

PCR test with results delivered within 24 hours. Designed for busy customers who can only visit testing centers in the afternoon; results typically received by the next business day. Priced at Rp275,000 per test.

4S-RBD Quantitative Antibody Test
CategoryDiagnostic testing service
Description

Blood test measuring immunity levels against COVID-19 by checking S-RBD antibodies. Helps individuals determine how immune they are against the virus. Priced at Rp249,000 per test.

5PCR Kumur (Gargle PCR / #AntiColok)
CategoryDiagnostic testing service
Description

Pain-free COVID-19 PCR test using gargle sample collection (no nasal/oral swab). First-in-Indonesia innovation with 93-98% sensitivity, branded #NoColok / #AntiColok. Comfortable for children and accepted for flight requirements. Priced at Rp350,000 per test.

6Drive/Walk Thru Testing
CategoryTesting service delivery option
Description

Contactless drive-thru and walk-in COVID-19 testing service available at 5 Greater Jakarta locations (Cilandak, Kuningan, Cengkareng, Bintaro, and Depok). Minimizes touch contact for a safe and comfortable testing experience and supports rapid 5-minute on-site registration.

7Home Services
CategoryTesting service delivery option
Description

Mobile COVID-19 testing service where GSI Lab professionals travel to the customer's location. Ideal for testing entire families or office groups who cannot travel to a fixed testing center, including Safety FamTrip packages for families.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
TypeOthers
Description

Oxford University donated laboratory equipment to GSI Lab, supporting their testing capabilities and infrastructure development.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

YAPPIKA Action Aid collaborated with GSI Lab on community health initiatives and social impact programs.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Prodia Widyahusada
TypeDirect peer
Description

Indonesia's largest independent clinical laboratory chain, offering a broad menu of diagnostic tests including PCR and molecular diagnostics. Directly comparable to GSI Lab as a private Indonesian clinical lab competing for corporate and consumer testing volumes.

TypeDirect peer
Description

Subsidiary of state-owned Kimia Farma, operating a nationwide network of clinical laboratories including PCR and COVID-19 testing services. Directly competes with GSI Lab in Indonesian diagnostic testing, particularly for government and corporate clients.

TypeDirect peer
Description

Major Indonesian private clinical laboratory network providing diagnostic testing across Java. Competes with GSI Lab for corporate health screening and outpatient diagnostic volumes.

TypeDirect peer
Description

Indonesian clinical laboratory offering PCR, genomic, and routine diagnostic services. Comparable mid-sized private Indonesian lab with similar customer mix including corporate and hospital referrals.

TypeDirect peer
Description

Indonesian clinical laboratory network with PCR and molecular diagnostic capabilities. Comparable private Indonesian lab competing in the same urban corporate and consumer testing market.

6Cito Indonesia (Laboratorium Cito)
TypeDirect peer
Description

Established Indonesian clinical laboratory with nationwide branches providing diagnostic and molecular testing. Competes with GSI Lab for corporate clients and broader diagnostic testing volumes in Indonesia.

TypeBroad incumbent
Description

US-based specialty molecular diagnostics company with strong PCR/NGS capabilities for reproductive health, oncology, and transplant testing. Comparable as a molecular-diagnostics lab that has built scale on proprietary PCR technology and clinical partnerships.

TypeEmerging player
Description

US-based health technology company offering population-scale genetic testing including COVID testing and genomic screening. Comparable emerging player that scaled lab operations around COVID-19 testing and is pivoting toward broader genomics.

TypeBroad incumbent
Description

Global diagnostics and laboratory equipment giant supplying PCR instruments and reagents used by labs including GSI Lab. Indirect peer as the infrastructure and assay provider shaping the competitive landscape.

TypeOthers
Description

Global supplier of PCR instruments, NGS platforms, and diagnostic reagents used by GSI Lab's laboratory operations. Relevant ecosystem participant that defines GSI Lab's technology and cost structure.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

GSI Lab

Medical Laboratory Servicesgsilab.id

GSI Lab is a Jakarta-based medical laboratory operating COVID-19 RT-PCR, antigen, and antibody testing across five Greater Jakarta locations, plus corporate on-site services and a government-affiliated whole genome sequencing surveillance program for SARS-CoV-2 variant tracking.

What GSI Lab does

GSI Lab (legally PT Genomik Solidaritas Indonesia) is a Jakarta-based medical laboratory founded in 2020 as a social entrepreneurship initiative to expand access to COVID-19 testing in Indonesia. The company operates five drive-thru and walk-in testing centers across the Greater Jakarta region (Cilandak, Kuningan, Cengkareng, Bintaro, and Depok) and offers home and on-site corporate testing services. Its core technology stack is RT-PCR plus rapid antigen and antibody testing, with a proprietary sample-collection innovation called PCR Kumur (#AntiColok), a first-in-Indonesia gargle-based RT-PCR method with reported 93-98% sensitivity. The lab also runs a Whole Genome Sequencing (WGS) capability through its #SolidaritySequence program, the only private laboratory supporting the Indonesian government's SARS-CoV-2 variant surveillance, and has contributed 4,600 WGS samples to the GISAID database.

The business operates on a unit-pricing, pay-as-you-go model across five core products (Swab Antigen at Rp95,000; 24-hour PCR at Rp275,000; PCR Kumur at Rp350,000; S-RBD Quantitative Antibody at Rp249,000; and Same-Day PCR at Rp450,000), distributed through direct-to-consumer channels (walk-in, drive-thru, home service) and an enterprise field sales motion targeting corporate clients such as Kredivo, Shopee, Indika Energy, Petrosea, Kideco, and Mobil. Cumulative outcomes include 700,000+ tests conducted and 6,000+ free PCR tests donated to frontliners and under-served communities, supported by Rp4.4 billion+ in cumulative donations from foundations (Temasek, Tanoto) and corporate sponsors. The company is officially registered as a Laboratorium Jejaring Pemeriksa COVID-19 with the Ministry of Health, integrated with the NAR reporting system and PeduliLindungi app.

In 2023 GSI Lab began extending beyond COVID-19 through the Batik Pelangi rare-disease genomic program (May 2023) and joined Filantropi Indonesia (February 2023), signaling a strategic pivot toward broader molecular diagnostics. Leadership is founder-led under CEO dr. Nino Susanto, with a Senior Research Fellow (PhD) and biomedical engineering staff supporting genomic R&D. Revenue has not been publicly disclosed, and the company remains a privately held social enterprise without documented institutional funding rounds beyond a 2022 investment associated with Alpha JWC Ventures / YCAB Ventures.

GSI Lab firmographics

Firmographics
Name
GSI Lab
Legal name
PT Genomik Solidaritas Indonesia
Website
https://gsilab.id
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
101–250 employees
Short description
GSI Lab is a Jakarta-based medical laboratory operating COVID-19 RT-PCR, antigen, and antibody testing across five Greater Jakarta locations, plus corporate on-site services and a government-affiliated whole genome sequencing surveillance program for SARS-CoV-2 variant tracking.
Ownership category
akta.pro rank

GSI Lab industry classification

Industry
Product category
Medical Laboratory Services
NAICS
Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAGAEAA
Central Laboratory Services (Core Lab Operations)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAJAIAN
Laboratory Informatics & Reporting (LIMS/ELR) Public Health Networks
Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Laboratories & Reference Testing Networks

Keywords

  • COVID-19 PCR testing
  • Medical laboratory services
  • Antigen rapid testing
  • Genomic surveillance services
  • Antibody blood testing

Where GSI Lab is headquartered

Location

Headquarters

HQ city
Jakarta
HQ country
Indonesia
HQ region
Asia

Offices2 records

Markets served

GSI Lab business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Supply Chain, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. COVID-19 Testing Services: Direct revenue from providing RT-PCR tests, rapid antigen tests, and antibody tests to individual consumers and corporate clients. Services offered at varying turnaround times and price points.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goSwab Antigen - Rapid Test
Unit PricingPay-as-you-goSame Day PCR Swab
Unit PricingPay-as-you-go24 Hour PCR Swab
Unit PricingPay-as-you-goS-RBD Quantitative Antibody Test
Unit PricingPay-as-you-goPCR Kumur (Gargle) Test

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

GSI Lab product offering

Product offering

Core offering

GSI Lab operates a private medical laboratory in Greater Jakarta providing COVID-19 testing services — antigen rapid tests, multiple PCR swab turnaround options (same-day and 24-hour), S-RBD quantitative antibody tests, and a proprietary gargle-based PCR (PCR Kumur / #AntiColok). It also runs Whole Genome Sequencing for SARS-CoV-2 variant surveillance and operates donation-funded free testing programs. Services are delivered via drive-thru/walk-in centers, home visits, and corporate on-site testing.

Product overview

GSI Lab (Genomik Solidaritas Indonesia) is a social entrepreneurship initiative providing COVID-19 testing services in Indonesia. The core offering consists of five main testing products: Swab Antigen (rapid test, 30-minute results), PCR Swab Same Day (same-day results), PCR Swab 24-hour (next-day results), S-RBD Quantitative Antibody Test (immunity measurement), and PCR Kumur (gargle-based PCR, #AntiColok innovation). These are delivered through three service channels: Drive/Walk Thru at 5 locations, Home Services for groups, and standard walk-in testing. GSI Lab also operates social programs including free PCR testing for frontliners (#SwabAndSave) and free Whole Genome Sequencing for variant surveillance (#SolidaritySequence). The company is registered as a COVID-19 testing laboratory affiliated with the Indonesian Ministry of Health's NAR system and connects results to the PeduliLindungi government app.

Differentiator

Problem solved

Functional benefit

Products and services

  • Swab Antigen Rapid COVID-19 antigen test using nasal swab sample collection. Provides results within 30 minutes. Most affordable testing option at Rp95,000 per test. Targeted at individual consumers and corporate clients needing fast, low-cost screening.
  • PCR Swab Same Day Same-day PCR test with results delivered by 23:59 on the same working day. Detects SARS-CoV-2 genetic material using nasal and oral swab sample collection, includes CT values. Most accurate detection method. Priced at Rp450,000 per test.
  • PCR Swab 24 jam PCR test with results delivered within 24 hours. Designed for busy customers who can only visit testing centers in the afternoon; results typically received by the next business day. Priced at Rp275,000 per test.
  • S-RBD Quantitative Antibody Test Blood test measuring immunity levels against COVID-19 by checking S-RBD antibodies. Helps individuals determine how immune they are against the virus. Priced at Rp249,000 per test.
  • PCR Kumur (Gargle PCR / #AntiColok) Pain-free COVID-19 PCR test using gargle sample collection (no nasal/oral swab). First-in-Indonesia innovation with 93-98% sensitivity, branded #NoColok / #AntiColok. Comfortable for children and accepted for flight requirements. Priced at Rp350,000 per test.
  • Drive/Walk Thru Testing Contactless drive-thru and walk-in COVID-19 testing service available at 5 Greater Jakarta locations (Cilandak, Kuningan, Cengkareng, Bintaro, and Depok). Minimizes touch contact for a safe and comfortable testing experience and supports rapid 5-minute on-site registration.
  • Home Services Mobile COVID-19 testing service where GSI Lab professionals travel to the customer's location. Ideal for testing entire families or office groups who cannot travel to a fixed testing center, including Safety FamTrip packages for families.

Quantifiable outcome

  • More than 700,000 tests conducted
  • +3 more outcomes

Companies that use GSI Lab

Customer profile

Named customers6 records

Segments2 records

Ideal customer profiles2 records

GSI Lab technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

Feature3 records

GSI Lab partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered minor.

  • Oxford UniversityOthersOxford University donated laboratory equipment to GSI Lab, supporting their testing capabilities and infrastructure development.
  • YAPPIKA Action AidminorStrategic or Co-development PartnerYAPPIKA Action Aid collaborated with GSI Lab on community health initiatives and social impact programs.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

GSI Lab competitors and assessment

Company assessment

Direct peers

  • Prodia Widyahusada: Indonesia's largest independent clinical laboratory chain, offering a broad menu of diagnostic tests including PCR and molecular diagnostics. Directly comparable to GSI Lab as a private Indonesian clinical lab competing for corporate and consumer testing volumes.
  • Kimia Farma Diagnostika: Subsidiary of state-owned Kimia Farma, operating a nationwide network of clinical laboratories including PCR and COVID-19 testing services. Directly competes with GSI Lab in Indonesian diagnostic testing, particularly for government and corporate clients.
  • Pramita Lab: Major Indonesian private clinical laboratory network providing diagnostic testing across Java. Competes with GSI Lab for corporate health screening and outpatient diagnostic volumes.
  • Bio Medika: Indonesian clinical laboratory offering PCR, genomic, and routine diagnostic services. Comparable mid-sized private Indonesian lab with similar customer mix including corporate and hospital referrals.
  • Biotest (Indonesia): Indonesian clinical laboratory network with PCR and molecular diagnostic capabilities. Comparable private Indonesian lab competing in the same urban corporate and consumer testing market.
  • Cito Indonesia (Laboratorium Cito): Established Indonesian clinical laboratory with nationwide branches providing diagnostic and molecular testing. Competes with GSI Lab for corporate clients and broader diagnostic testing volumes in Indonesia.

Broad incumbents

  • Natera: US-based specialty molecular diagnostics company with strong PCR/NGS capabilities for reproductive health, oncology, and transplant testing. Comparable as a molecular-diagnostics lab that has built scale on proprietary PCR technology and clinical partnerships.
  • Siemens Healthineers (Laboratory Diagnostics): Global diagnostics and laboratory equipment giant supplying PCR instruments and reagents used by labs including GSI Lab. Indirect peer as the infrastructure and assay provider shaping the competitive landscape.

Emerging players

  • Color Health: US-based health technology company offering population-scale genetic testing including COVID testing and genomic screening. Comparable emerging player that scaled lab operations around COVID-19 testing and is pivoting toward broader genomics.

Others

  • Thermo Fisher Scientific (Clinical Diagnostics): Global supplier of PCR instruments, NGS platforms, and diagnostic reagents used by GSI Lab's laboratory operations. Relevant ecosystem participant that defines GSI Lab's technology and cost structure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

GSI Lab social profiles

Digital presence

GSI Lab compliance and trust

Trust signal

Compliance2 records

GSI Lab financial estimates

Financial estimate

Revenue estimate

Valuation estimate

GSI Lab leadership team

Management profile

Number of profiles

Profiles5 records

GSI Lab funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

GSI Lab M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GSI Lab

What does GSI Lab do?

GSI Lab operates a private medical laboratory in Greater Jakarta providing COVID-19 testing services — antigen rapid tests, multiple PCR swab turnaround options (same-day and 24-hour), S-RBD quantitative antibody tests, and a proprietary gargle-based PCR (PCR Kumur / #AntiColok). It also runs Whole Genome Sequencing for SARS-CoV-2 variant surveillance and operates donation-funded free testing programs. Services are delivered via drive-thru/walk-in centers, home visits, and corporate on-site testing.

Is GSI Lab a public or private company?

GSI Lab is a private company. It is classified as venture growth investor backed and is currently operating.

When was GSI Lab founded?

GSI Lab was founded in 2020. It employs 101 to 250 people.

Where is GSI Lab based?

GSI Lab is headquartered in Jakarta, Indonesia, in the Asia region.

How does GSI Lab make money?

One revenue line is on record: COVID-19 Testing Services.

Who are GSI Lab's main competitors?

Direct peers on record are Prodia Widyahusada, Kimia Farma Diagnostika, Pramita Lab, Bio Medika, Biotest (Indonesia) and Cito Indonesia (Laboratorium Cito). Broad incumbents are Natera and Siemens Healthineers (Laboratory Diagnostics). Color Health is listed as an emerging player. Thermo Fisher Scientific (Clinical Diagnostics) is listed as an others.

Does GSI Lab have an API?

No public API is recorded for GSI Lab.

What industry is GSI Lab in?

GSI Lab's product category is Medical Laboratory Services. Its primary akta.pro industry code is HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR), with a secondary code of HLAGAEAA, Central Laboratory Services (Core Lab Operations). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales